Pharmapedia

“Large numbers of drugs are banned by most of European countries but still they are easily available in Indian market. Long term use of such medicines can put negative impact on human health in various ways by damaging liver or any other organ, depression, blood pressure fluctuations etc. A ban is needed to protect the public’s health and the quality of health care. A ban will require self-examination by the public, health care professions, PhRMA, and the health care policy community.

Insufficient clinical data, lack of large scale and well defined investigation plan on wide scale on various territories with a common goal are some of the deterrents which are not permitting gelling of these three with allopathic medicines. If sole herbals are not very effective then the only option is to marry these with well defined and recommended allopathic medicine to make powerful formulae for existing medical problems.

The success of a drug molecule or formulation lies in its switching over to OTC (over the counter) genre from prescription drugs (Rx) over the years. No doubt critical therapy like chemotherapy, cardio medicines and others cannot /should not be promoted as OTC.

Loss of appetite during illness is a common and potentially debilitating phenomenon—in cancer patients, especially, it can even shorten lifespan. Researchers of the Scripps Research Institute (TSRI) have discovered how an immune system molecule hijacks a brain circuit and reduces appetite. Their discovery points to possible targets for treating loss of appetite and restoring a patient’s strength.

“After the colonial era, cost of drugs in India had inherited British patent law, and the average Indian citizen unable to afford pharmaceutical medicines.  So in 1970, India passed the Patent Act, which allowed Indian companies to make cheaper copies of another company’s drug (or other inventions) as long the manufacturing process was slightly different.